BTT-369 

BTT-369 is a Ca_Vα₁·Ca_Vβ₃ protein-protein complex antagonist with a K_i of 2.0 μM. BTT-369 inhibits Ca_V2.2 currents, with an apparent IC₅₀ value of 31 μM. BTT-369 disrupts the interaction between Ca_Vα₁ and Ca_Vβ₃ subunits. BTT-369 reduces the current density of Ca_V2.2, and shifts the voltage dependence of steady-state inactivation and activation of Ca_V2.2 to more positive potentials. BTT-369 alleviates mechanical hyperalgesia in a rat model of tibial nerve injury. BTT-369 can be used for the study of neuropathic pain^[1].

BTT-369 potently inhibits the protein-protein interaction between purified Ca_Vα₁-AID and Ca_Vβ₃, with a K_i value of 2.0 μM^[1].
BTT-369 (0.1-100 μM; 5 min-48 h) reduces Ca_V2.2 current density in HEK-CaV2.2 cells, and shifts the voltage dependence of Ca_V2.2 activation and steady-state inactivation toward more positive potentials^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

BTT-369 (0.1 mg/kg; i.p.; single bolus injection) significantly reverses mechanical hypersensitivity in a rat tibial nerve injury model of neuropathic pain for at least 24 hours^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

580.64

C₃₄H₂₈N₈O₂

2413939-96-3

O=C(C1=CC=CC(C2=NN=NN2)=C1)N3N=C(C4=CC=C(OC)C=C4)CC3C5=CN(C6=CC=CC=C6)N=C5C7=CC=C(C)C=C7

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Chen X, et al. Small-molecule Ca_Vα₁⋅Ca_Vβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking. Proc Natl Acad Sci U S A. 2018;115(45):E10566-E10575.  [Content Brief]